David McNeil
Psychiatry · Buffalo Grove, ILNPI 1881652154
Payments from drug & device makers
Across 434 payments — averaging $30.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$733
- Corium, LLC$536
- Neos Therapeutics, LP$486
- Takeda Pharmaceuticals U.S.A., Inc.$455
- plus $4K from 24 others
What the payments were for
- Speaking & faculty fees$4,96038%
- Food & beverage$8,07362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 73 | $5,728 |
| Otsuka America Pharmaceutical, Inc. | 53 | $1,037 |
| Johnson & Johnson | 47 | $733 |
| Corium, LLC | 25 | $536 |
| Neos Therapeutics, LP | 14 | $486 |
| Takeda Pharmaceuticals U.S.A., Inc. | 38 | $455 |
| Sunovion Pharmaceuticals Inc. | 22 | $451 |
| Lundbeck LLC | 29 | $426 |
| Ironshore Pharmaceuticals Inc. | 13 | $410 |
| Neurocrine Biosciences, Inc. | 15 | $358 |
| Teva Pharmaceuticals USA, Inc. | 12 | $333 |
| Jazz Pharmaceuticals Inc. | 10 | $271 |
| Supernus Pharmaceuticals, Inc. | 10 | $268 |
| Tris Pharma Inc | 4 | $251 |
| Alkermes, Inc. | 11 | $239 |
| Bausch Health US, LLC | 11 | $202 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $198 |
| Adlon Therapeutics L.p. | 7 | $109 |
| Almatica Pharma LLC | 5 | $84 |
| Harmony Biosciences LLC | 4 | $82 |
| Eisai Inc. | 4 | $61 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Validus Pharmaceuticals LLC | 1 | $52 |
| Arbor Pharmaceuticals, Inc. | 3 | $48 |
| Avanir Pharmaceuticals, Inc. | 2 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Shire North American Group Inc | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Neuronetics, Inc. | 2 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$4,960
- Adzenys XR-ODT$355
- Azstarys$230
- QELBREE$125
- Quillichew ER$125
- Dyanavel XR$125
- Quillivant$125
- JORNAY PM$124
- REXULTI$122
- INGREZZA$122
- NUEDEXTA$121
- Jornay PM 20mg capsules (Bottle of 100)$116
- Cotempla XR-ODT$112
- Karbinal$112
How this compares
$13,033 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Buffalo Grove
- Jeffrey RossNorthbrook$10.8M
- Yuhwen ChowChicago$8.5M
- Mark LermanNorthbrook$4.5M
- Danesh AlamWinfield$2.7M
- John ZajeckaSkokie$2.5M
- Riaz BaberNaperville$2.4M
- Michael GreenbaumLibertyville$2.2M
- Sandeep GaonkarNaperville$1.8M
- Jon GrantChicago$1.4M
- David KempOak Lawn$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.